Fred Grossman - 17 Jul 2023 Form 4 Insider Report for Coya Therapeutics, Inc. (COYA)

Role
Chief Medical Officer
Signature
/s/ David Snyder, Attorney-in-Fact
Issuer symbol
COYA
Transactions as of
17 Jul 2023
Net transactions value
$0
Form type
4
Filing time
19 Jul 2023, 21:05:05 UTC
Next filing
02 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COYA Stock Option (right to buy) Award +74,069 74,069 17 Jul 2023 Common Stock, par value $0.0001 per share 74,069 $4.25 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to continuous service, 24,689 of the shares subject to the option will vest on July 17, 2024, and the remaining shares will vest in equal monthly installments over a period of 24 months commencing on August 17, 2024.